[1] 国家卫生健康委员会. 卫生健康委关于印发严重精神障碍管理治疗工作规范(2018年版)的通知[J]. 中华人民共和国国务院公报,2018(31):76-90. [2] 王勋,马宁,吴霞民,等. 2018年全国严重精神障碍患者管理治疗现状分析[J]. 中华精神科杂志,2020,53(5):438-445. [3] Moore TJ, Furberg CD.The harms of antipsychotic drugs: Evidence from key studies[J]. Drug Saf, 2017, 40(1): 3-14. [4] 海帆,张宝琴,乔璟,等. 郑州市严重精神障碍患者服药依从性的影响因素[J]. 四川精神卫生,2022,35(6):531-536. [5] 吴越,范洁,包炤华,等. 无锡市社区严重精神障碍患者服药依从性及其影响因素研究[J]. 中国全科医学,2020,23(4):490-494. [6] 梁昌权,谭文艳,陈潮立,等. 江门市严重精神障碍患者服药依从性及影响因素研究[J]. 临床心身疾病杂志,2021,27(5):88-91. [7] 邓云龙,李志芸,洪建河. 2015年海南省严重精神障碍患者管理信息分析[J]. 海南医学,2017,28(5):836-839. [8] 罗建军,蒋国庆,杨天翼. 2016年重庆市严重精神障碍患者管理治疗信息分析[J]. 精神医学杂志,2018,31(3):200-204. [9] Chai X, Liu Y, Mao Z, et al.Barriers to medication adherence for rural patients with mental disorders in eastern China: A qualitative study[J]. BMC Psychiatry, 2021, 21(1): 141. [10] Zhu J, Huang Q, Lu W, et al.Do community free-medication service policy improve patient medication adherence? A cross-sectional study of patients with severe mental disorders in Beijing community[J]. Front Public Health, 2021, 9: 714374. [11] Deng M, Zhai S, Ouyang X, et al.Factors influencing medication adherence among patients with severe mental disorders from the perspective of mental health professionals[J]. BMC Psychiatry, 2022, 22(1): 22. [12] Grover S, Avasthi A, Singh A, et al.Stigma experienced by patients with severe mental disorders: A nationwide multicentric study from India[J]. Psychiatry Res, 2017, 257: 550-558. [13] Whiting D, Lichtenstein P, Fazel S.Violence and mental disorders: A structured review of associations by individual diagnoses, risk factors, and risk assessment[J]. Lancet Psychiatry, 2021, 8(2): 150-161. |